HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Anti-Aging Movement Reaches New Demographics, Product Categories

This article was originally published in The Rose Sheet

Executive Summary

The anti-aging trend is sweeping into new demographics and product categories that represent fresh opportunities for personal-care firms, according to Amy Ziegler, global personal-care analyst at Mintel International.

You may also be interested in...



New Anti-Aging Line Maximizes Antioxidant Potency For Radical Results

While antioxidant oomph is a common boast among marketers of anti-aging skin-care lines, sometimes the potency of even the most expensive product is sacrificed when those antioxidants are mixed with an emollient or cream base.

Specialty Channel Targeted For Palomar Home-Use Laser After Split With J&J

Palomar Medical Technologies will roll-out its FDA-cleared home-use anti-wrinkle device to specialty markets late next year despite the termination of a deal with Johnson & Johnson that would have taken the product into the mass channel

Euromonitor: Value Shopping, Gender-Blurring Among Top Consumer Trends For 2106

A new report from market-research firm Euromonitor International suggests that global consumption in the coming year will see a blend of established, new and counter trends, challenging the way consumers live and shop. Within beauty, marketers may seize on the trends of value shopping, gender-blurring and embracing of aging to reach discriminating consumers in 2016.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017808

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel